Article
Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
Journal of cardiovascular electrophysiology - 1 Aug 2006
Meregalli Paola G, Ruijter Jan M, Hofman Nynke, Bezzina Connie R, Wilde Arthur A M, Tan Hanno L
Abstract excerpt
INTRODUCTION: Provocation tests with sodium channel blockers are often required to unmask ECG abnormalities in Brugada syndrome (BrS). However, their diagnostic value is only partially established, while life-threatening ventricular arrhythmias during these tests were reported. We aimed to establish sensitivity, specificity, and safety of flecainide testing, and to predict a positive test outcome from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
